5脂氧合酶激活蛋白抗體 返回列表頁

5脂氧合酶激活蛋白抗體

英文名稱 FLAP
中文名稱 5脂氧合酶激活蛋白抗體
別    名 5-lipoxygenase activating protein; Arachidonate 5 lipoxygenase activating protein; 5-lipoxygenase activating protein; AL5AP_HUMAN; ALOX 5AP; ALOX5 AP; ALOX5AP; Arachidonate 5-lipoxygenase-activating protein; Five lipoxygenase activating protein; FLAP; MK 886 binding protein; MK-886-binding protein.
  
說 明 書 0.2ml  
研究領(lǐng)域 心血管  細(xì)胞生物  免疫學(xué)  信號轉(zhuǎn)導(dǎo)  
抗體來源 Rabbit
克隆類型 Polyclonal
交叉反應(yīng) Human, Mouse, Pig, Cow, Horse, Rabbit, Sheep, 
產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 （石蠟切片需做抗原修復(fù)） 
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
分 子 量 18kDa
細(xì)胞定位 細(xì)胞核 細(xì)胞漿 細(xì)胞膜 
性    狀 Lyophilized or Liquid
濃    度 1mg/1ml
免 疫 原 KLH conjugated synthetic peptide derived from human FLAP/5-lipoxygenase activating protein
亞    型 IgG
純化方法 affinity purified by Protein A
儲(chǔ) 存 液 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.

PubMed PubMed
產(chǎn)品介紹 background:
Required for leukotriene biosynthesis by ALOX5 (5-lipoxygenase). Anchors ALOX5 to the membrane. Binds arachidonic acid, and could play an essential role in the transfer of arachidonic acid to ALOX5. Binds to MK-886, a compound that blocks the biosynthesis of leukotrienes.
Involvement in disease: Genetic variations in ALOX5AP may be a cause of susceptibility to ischemic stroke (ISCHSTR) ; also known as cerebrovascular accident or cerebral infarction. A stroke is an acute neurologic event leading to death of neural tissue of the brain and resulting in loss of motor, sensory and/or cognitive function. Ischemic strokes, resulting from vascular occlusion, is considered to be a highly complex disease consisting of a group of heterogeneous disorders with multiple genetic and environmental risk factors.xy-6423R    PI3 Kinase p110 beta磷脂酰肌醇激酶（PI3Kβ）抗體
xy-6918R    PPAPDC3磷脂酸磷酸酶2結(jié)構(gòu)域3抗體
xy-6904R    PRC1胞質(zhì)分裂調(diào)控蛋白1抗體
xy-6419R    phospho-PP2A alpha+beta(Tyr307)磷酸化蛋白磷酸酶2A（PP2Aα）抗體
xy-8062R    PLEKHM1石骨癥相關(guān)蛋白PLEKHM1抗體
xy-8063R    PLEKHM2血小板白細(xì)胞C激酶底物同源結(jié)構(gòu)域M2抗體
xy-8064R    PLEKHM3血小板白細(xì)胞C激酶底物同源結(jié)構(gòu)域M3抗體
xy-2138R    PARP多腺苷二磷酸多聚酶抗體(N端)
xy-11471R    PTPRD酪氨酸磷酸酶PTPδ抗體 蛋白酪氨酸磷酸酶D受體抗體
xy-11123R    PCDHA10/CNRN8鈣粘蛋白相關(guān)神經(jīng)受體8抗體
xy-11112R    PCDH18原鈣粘附蛋白18抗體
xy-11113R    PCDH20原鈣粘附蛋白20抗體
xy-11114R    PCDH8原鈣粘附蛋白8抗體
xy-6371R    Protamine 2魚精蛋白2抗體
xy-6853R    PIWIL4piwi樣4蛋白抗體
xy-6348R    PIWIL3piwi樣3蛋白抗體
xy-4743R    PRRSV豬繁殖與呼吸綜合征/豬藍(lán)耳病病毒抗體
xy-6847R    PDCD10凋亡相關(guān)蛋白10抗體
xy-7595R    PPM1F鈣調(diào)蛋白依賴性蛋白激酶磷酸酶抗體
xy-4852R    PIM3絲氨酸/蘇氨酸蛋白激酶PIM3抗體
xy-6992R    PRMT5組蛋白精氨酸甲基轉(zhuǎn)移酶5抗體
xy-11107R    PCDH11X原鈣粘附蛋白11X抗體
xy-11108R    PCDH11Y原鈣粘附蛋白11Y抗體
xy-11109R    PCDH12原鈣粘附蛋白12/血管內(nèi)皮鈣粘蛋白2抗體
xy-11110R    PCDH17原鈣粘附蛋白17抗體
xy-11111R    PCDH1原鈣粘附蛋白1抗體
xy-11115R    PCDHA1原鈣粘附蛋白α1抗體
xy-11117R    PCDHA3原鈣粘附蛋白α3抗體
xy-11118R    PCDHA4原鈣粘附蛋白α4抗體
xy-11119R    PCDHA5原鈣粘附蛋白α5抗體
xy-11120R    PCDHA9原鈣粘附蛋白α9抗體
xy-11121R    PCDHA7原鈣粘附蛋白α7抗體
xy-11122R    PCDHA8原鈣粘附蛋白α8抗體